avantdrug is the preclinical studies area of Creatio, dedicated to the validation of new technologies and healthcare products under development for their regulatory approval.
With extensive experience in the field, our skilled professionals provide private and public sector clients with a wide range of preclinical studies conducted under high quality standards, ISO 9001:2015 and/or GLP quality standards, as well as technical and scientific advisory services.
avantdrug aims to become the foremost preclinical research center of its kind, setting a benchmark for preclinical studies that promote the timely and cost-effective launch of innovative, safe and effective products for the benefit of the society.
AVANTDRUG INFORMATION
